Echocardiography image analysis software developer DiACardio has changed its name to DiA Imaging Analysis.
The name change reflects an expansion of the company's strategic mission to new segments in the image analysis market in addition to its original focus in echocardiography, according to the Beersheba, Israel-based firm. DiA Imaging Analysis has received U.S. Food and Drug Administration (FDA) clearance and the European CE Mark for two cardiac imaging analysis applications.
The vendor's cognitive image processing technology is based on pattern recognition and machine-learning algorithms.
